LABP
Price:
$22.93
Market Cap:
$71.68M
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therape...[Read more]
Industry
Biotechnology
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
LABP
According to Landos Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -73.00%. This represents a change of 254.82% compared to the average of -20.57% of the last 4 quarters.
The mean historical ROE of Landos Biopharma, Inc. over the last ten years is -118.39%. The current -73.00% ROE has changed -38.34% with respect to the historical average. Over the past ten years (40 quarters), LABP's ROE was at its highest in in the December 2020 quarter at 21.00%. The ROE was at its lowest in in the March 2024 quarter at -38.43%.
Average
-118.39%
Median
-59.56%
Minimum
-604.40%
Maximum
55.81%
Discovering the peaks and valleys of Landos Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.71%
Maximum Annual ROE = 55.81%
Minimum Annual Increase = -189.81%
Minimum Annual ROE = -604.40%
Year | ROE | Change |
---|---|---|
2023 | -69.00% | -28.93% |
2022 | -97.09% | 93.71% |
2021 | -50.12% | -189.81% |
2020 | 55.81% | 2.48% |
2019 | 54.45% | -109.01% |
The current ROE of Landos Biopharma, Inc. (LABP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-72.07%
5-year avg
-21.19%
10-year avg
-118.39%
Landos Biopharma, Inc.’s ROE is less than eFFECTOR Therapeutics, Inc. (2.18%), less than Apexigen, Inc. (48.27%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Angion Biomedica Corp. (-98.89%), less than Oncorus, Inc. (0%), greater than Apollomics, Inc. (-82.19%), greater than Cardio Diagnostics Holdings, Inc. (-184.11%), greater than TransCode Therapeutics, Inc. (-258.81%), greater than NexImmune, Inc. (-649.01%), greater than Xenetic Biosciences, Inc. (-526.91%), greater than null (-49.49%),
Company | ROE | Market cap |
---|---|---|
2.18% | $941.00 | |
48.27% | $9.57M | |
-173.56% | $100.08K | |
-98.89% | $30.11M | |
0% | $0 | |
-82.19% | $9.98M | |
-184.11% | $10.73M | |
-258.81% | $6.64M | |
-649.01% | $488.13K | |
-526.91% | $6.33M | |
-49.49% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Landos Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Landos Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Landos Biopharma, Inc.'s ROE?
How is the ROE calculated for Landos Biopharma, Inc. (LABP)?
What is the highest ROE for Landos Biopharma, Inc. (LABP)?
What is the 3-year average ROE for Landos Biopharma, Inc. (LABP)?
What is the 5-year average ROE for Landos Biopharma, Inc. (LABP)?
How does the current ROE for Landos Biopharma, Inc. (LABP) compare to its historical average?